Evaluation of the near infrared compound indocyanine green as a probe substrate of P-glycoprotein

Molecular Pharmaceutics

Volumn 9, Issue 12, 2012, Pages 3595-3601

  Portnoy, Emma ^a,b   Gurina, Marina ^a   Magdassi, Shlomo ^b   Eyal, Sara ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

BCRP; breast cancer resistance protein; indocyanine green; MDR1; Mdr2; MRP2; multidrug resistance associated protein; near infrared optical imaging; P glycoprotein

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; INDOCYANINE GREEN; MULTIDRUG RESISTANCE PROTEIN; VALSPODAR;

ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; IN VIVO STUDY; INFRARED RADIATION; MOUSE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; BRAIN; COLORING AGENTS; CYCLOSPORINS; DOGS; HUMANS; INDOCYANINE GREEN; MADIN DARBY CANINE KIDNEY CELLS; MALE; MICE; P-GLYCOPROTEIN; PILOT PROJECTS; SPECTROSCOPY, NEAR-INFRARED; TISSUE DISTRIBUTION;

EID: 84870566582     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300472y     Document Type: Article

References (27)

1. Cordon-Cardo, C.; OBrien, J. P.; Boccia, J.; Casals, D.; Bertino, J. R.; Melamed, M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues J. Histochem. Cytochem. 1990, 38 (9) 1277-87 (Pubitemid 20266126)
2. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (21) 7735-8
3. Maliepaard, M.; Scheffer, G. L.; Faneyte, I. F.; van Gastelen, M. A.; Pijnenborg, A. C.; Schinkel, A. H.; van De Vijver, M. J.; Scheper, R. J.; Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 2001, 61, 3458-64 (Pubitemid 32695041)
4. Eyal, S.; Hsiao, P.; Unadkat, J. D. Drug interactions at the blood-brain barrier: fact or fantasy? Pharmacol. Ther. 2009, 123, 80-104
5. Kannan, P.; John, C.; Zoghbi, S. S.; Halldin, C.; Gottesman, M. M.; Innis, R. B.; Hall, M. D. Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications Clin. Pharmacol. Ther. 2009, 86, 368-77
6. Sasongko, L.; Link, J. M.; Muzi, M.; Mankoff, D. A.; Yang, X.; Collier, A. C.; Shoner, S. C.; Unadkat, J. D. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography Clin. Pharmacol. Ther. 2005, 77, 503-14 (Pubitemid 40824964)
7. 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein J. Nucl. Med. 2009, 50, 807-13
8. Bauer, M.; Zeitlinger, M.; Karch, R.; Matzneller, P.; Stanek, J.; Jäger, W.; Böhmdorfer, M.; Wadsak, W.; Mitterhauser, M.; Bankstahl, J. P.; Löscher, W.; Koepp, M.; Kuntner, C.; Müller, M.; Langer, O. Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data Clin. Pharmacol. Ther. 2012, 91, 227-33
9. On, N. H.; Chen, F.; Hinton, M.; Miller, D. W. Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques Pharm. Res. 2011, 28, 2505-15
10. Dzurinko, V. L.; Gurwood, A. S.; Price, J. R. Intravenous and indocyanine green angiography Optometry 2004, 75, 743-55
11. Sakka, S. G. Assessing liver function Curr. Opin. Crit. Care 2007, 13, 207-14 (Pubitemid 46328337)
12. Larush, L.; Magdassi, S. Formation of near-infrared fluorescent nanoparticles for medical imaging Nanomedicine (London) 2011, 6, 233-40
13. Portnoy, E.; Lecht, S.; Lazarovici, P.; Danino, D.; Magdassi, S. Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging Nanomedicine (London) 2011, 7, 480-8
14. Zhang, Y.; Gupta, A.; Wang, H.; Zhou, L.; Vethanayagam, R. R.; Unadkat, J. D.; Mao, Q. BCRP transports dipyridamole and is inhibited by calcium channel blockers Pharm. Res. 2005, 22, 2023-34 (Pubitemid 41821581)
15. FDA Draft Guidance for Industry: Drug Interaction Studies-Study Design, 2006.
16. Rautio, J.; Humphreys, J. E.; Webster, L. O.; Balakrishnan, A.; Keogh, J. P.; Kunta, J. R.; Serabjit-Singh, C. J.; Polli, J. W. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates Drug Metab. Dispos. 2006, 34, 786-92
17. Ni, Z.; Bikadi, Z.; Cai, X.; Rosenberg, M. F.; Mao, Q. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport Am. J. Physiol. 2010, 299, C1100-9
18. Robey, R. W.; Honjo, Y.; van de Laar, A.; Miyake, K.; Regis, J. T.; Litman, T.; Bates, S. E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2) Biochim. Biophys. Acta 2001, 1512, 171-82 (Pubitemid 32530764)
19. Niemann, C.; Henthorn, T.; Krejcie, T.; Shanks, C.; Enders-Klein, C.; Avram, M. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol Clin. Pharmacol. Ther. 2000, 67, 342-50 (Pubitemid 30246809)
20. Poller, B.; Wagenaar, E.; Tang, S. C.; Schinkel, A. H. Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier Mol. Pharmaceutics 2011, 8, 571-82
21. Jansen, P. L.; van Klinken, J. W.; van Gelder, M.; Ottenhoff, R.; Oude Elferink, R. P. J. Preserved organic anion transport in mutant TR- rats with a hepatobiliary secretion defect Am. J. Physiol. 1993, 28, G445-G453
22. Feng, B.; Mills, J. B.; Davidson, R. E.; Mireles, R. J.; Janiszewski, J. S.; Troutman, M. D.; de Morais, S. M. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system Drug Metab. Dispos. 2008, 36, 268-75 (Pubitemid 351185738)
23. Oostendorp, R. L.; van de Steeg, E.; van der Kruijssen, C. M.; Beijnen, J. H.; Kenworthy, K. E.; Schinkel, A. H.; Schellens, J. H. Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors Drug Metab. Dispos. 2009, 37, 917-23
24. Huang, L.; Vore, M. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green Drug Metab. Dispos. 2001, 29, 634-7 (Pubitemid 32374562)
25. Sathirakul, K.; Suzuki, H.; Yamada, T.; Hanano, M.; Sugiyama, Y. Multiple transport systems for organic anions across the bile canalicular membrane J. Pharmacol. Exp. Ther. 1994, 268, 65-73 (Pubitemid 24039069)
26. Polom, K.; Murawa, D.; Rho, Y. S.; Nowaczyk, P.; Hünerbein, M.; Murawa, P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review Cancer 2011, 117, 4812-22
27. Yamamoto, M.; Sasaguri, S.; Sato, T. Assessing intraoperative blood flow in cardiovascular surgery Surg. Today 2011, 41, 1467-74